Skip to main navigation
Skip to search
Skip to main content
Penn State Home
Help & FAQ
Home
Researchers
Research output
Research units
Equipment
Grants & Projects
Prizes
Activities
Search by expertise, name or affiliation
The use of neuroproteomics in drug abuse research
Melinda E. Lull
, Willard M. Freeman
, Heather D. VanGuilder
,
Kent E. Vrana
Penn State Neuroscience Institute
Center for Cannabis and Natural Product Pharmaceuticals (CCNPP)
Department of Molecular and Precision Medicine
Research output
:
Contribution to journal
›
Review article
›
peer-review
15
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The use of neuroproteomics in drug abuse research'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Discovery Proteomics
14%
Epigenetic Methods
14%
Genomic Methods
14%
Model Proteins
14%
Neurobiological Changes
14%
Neurobiology of Addiction
14%
Neuroproteomics
100%
Omics Technologies
14%
Protein Sample
14%
Proteome Fractionation
14%
Proteomic Study
28%
Sample Quality
14%
Sample Stability
14%
Medicine and Dentistry
Addictive Behavior
28%
Drug Abuse
100%
Proteomics
57%
Substance Use Disorder
14%
Therapeutic Agent
14%
Transcriptomics
14%
Two Dimensional Difference Gel Electrophoresis
14%
Neuroscience
Behavior (Neuroscience)
14%
Drug Abuse
100%
Neuroscience
14%
Physical Dependence
14%
Proteomics
57%
Transcriptomics
14%
Biochemistry, Genetics and Molecular Biology
Neuroproteomics
100%